Drreddys Laboratories | Ativo Circulante



Current Assets Alterar Data
ANI Pharmaceuticals USD 536.29M 8.61M 2025-03
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Bayer EUR 34.83B 388M 2025-03
Canopy Growth CAD 341.08M 50.58M 2024-12
Cipla INR 232.89B 23.43B 2025-03
Corcept Therapeutics USD 443.11M 4.61M 2025-06
Drreddys Laboratories INR 253.02B 4.89B 2024-12
GlaxoSmithKline GBP 17.67B 412M 2025-06
Hikma Pharmaceutical USD 2.26B 22M 2024-12
Lonza CHF 5.44B 113M 2024-12
Novartis USD 25.94B 831M 2025-06
Pacira USD 745.61M 14.35M 2025-06
Prestige Brands USD 480.52M 32.19M 2025-06
Richter Gedeon HUF 641.06B 69.19B 2024-12
Sun Pharmaceuticals INR 525.94B 64.89B 2025-03
Supernus Pharmaceuticals USD 738.87M 51.28M 2025-06
Teva Pharmaceutical Industries USD 12.62B 1.09B 2025-06


Drreddys Laboratories Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.